Lichen China Ltd (LICN)

Lichen China Ltd (NASDAQ: LICN) is a common stock listing of an investment holding company that operates in the People’s Republic of China. Through its businesses, the company provides financial and taxation services, education support services, and software and maintenance services. Its financial and taxation segment includes management consultation, internal control consultation, regular and annual advisory work, internal training, and general consulting. The education support business covers marketing, operational, and technical support, along with the sale of teaching and learning materials. The software and maintenance business includes financial and taxation analysis software and training software, as well as installation, training, after-sales technical support, and maintenance services. The company serves a range of clients, including listed companies, state-owned enterprises, government authorities, and small and medium-sized enterprises. Incorporated in 2016 and based in Xiamen, China, it changed its name from Lichen China Limited to Lichen International Limited in March 2025.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-LICN
$1.29
19.4% Upside
Undervalued
Not available
Not available
Weak
0.0%
0.3x
0.7x
17.752 M
-8.608 M
3.1%
99.3%
20.7
81.4%
Valuation • Fair Value

Lichen China Ltd (NASDAQ-LICN) Fair Value by Valuation Model

Review the available estimates for Lichen China Ltd (NASDAQ-LICN), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$1.29

Estimated upside of 19.4% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$1.16

Discounted cash flow valuation reference.

Comps Fair Value

$1.35

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Lichen China Ltd (NASDAQ-LICN) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Lichen China Ltd (NASDAQ-LICN)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

24.518 M

Current operating scale indicator.

Revenue Forecast

24.518 M

Forward revenue estimate.

EBITDA

-13.705 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Lichen China Ltd (NASDAQ-LICN) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Lichen China Ltd (NASDAQ-LICN)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

1

Weak quality score that deserves closer review.

Beneish M-Score

-2.94

No elevated caution signal from this screen.

Altman Z-Score

20.7

Relatively strong balance-sheet zone.

FCF / Net Income

81.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Lichen China Ltd (NASDAQ-LICN). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Lichen China Ltd (NASDAQ-LICN)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Lichen China Ltd (NASDAQ-LICN). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Lichen China Ltd (NASDAQ-LICN) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Lichen China Ltd (NASDAQ-LICN) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Lichen China Ltd (NASDAQ-LICN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Lichen China Ltd (NASDAQ-LICN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Lichen China Ltd (NASDAQ-LICN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Lichen China Ltd (NASDAQ-LICN) Stock FAQ

Data-supported answers about Lichen China Ltd (NASDAQ-LICN), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$1.29
Estimated upside 19.4%
Valuation Rating
Undervalued
Estimated upside of 19.4%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Lichen China Ltd (NASDAQ-LICN) is $1.29. This implies an estimated upside of 19.4% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 19.4% versus the current market price.

The current financial health read for Lichen China Ltd (NASDAQ-LICN) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Lichen China Ltd (NASDAQ-LICN).

The current market capitalization listed for Lichen China Ltd is 17.752 M.

The current enterprise value listed for Lichen China Ltd is -8.608 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Lichen China Ltd is NASDAQ-LICN, and the stock is listed on NASDAQ.

Lichen China Ltd (NASDAQ-LICN) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Lichen China Ltd is 3.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Lichen China Ltd is 99.3%. Free float helps investors understand how much of the share base is available for public trading.